Compounds > transferrin
Page last updated: 2024-08-23

transferrin and ER-Negative PR-Negative HER2-Negative Breast Cancer

transferrin has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Ghosh, SS; Shome, R1
Batista, AA; Cominetti, MR; Correa, RS; Graminha, AE; Honorato, J; Menezes, ACS1
Abdel-Atti, D; Dilling, TR; Edwards, KJ; Evans, MJ; Henry, KE; Lewis, JS1
DeVaux, RS; Espinal, R; Hepel, M; Herschkowitz, JI; Kurzatkowska, K; Santiago, T1
Jadia, R; Kydd, J; Rai, P1
Batista, AA; Cominetti, MR; Graminha, AE; Honorato, J; Luna-Dulcey, L; Menezes, ACS; Naves, MA; Vegas, LC1

Other Studies

6 other study(ies) available for transferrin and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Transferrin Coated d-penicillamine-Au-Cu Nanocluster PLGA Nanocomposite Reverses Hypoxia-Induced EMT and MDR of Triple-Negative Breast Cancers.
    ACS applied bio materials, 2021, 06-21, Volume: 4, Issue:6

    Topics: Apoptosis; beta Catenin; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Survival; Copper; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Erythrocytes; Female; Gold; Humans; Nanostructures; Penicillamine; Polylactic Acid-Polyglycolic Acid Copolymer; Reactive Oxygen Species; Transferrin; Triple Negative Breast Neoplasms

2021
A novel ruthenium(ii) gallic acid complex disrupts the actin cytoskeleton and inhibits migration, invasion and adhesion of triple negative breast tumor cells.
    Dalton transactions (Cambridge, England : 2003), 2021, Jan-07, Volume: 50, Issue:1

    Topics: Actin Cytoskeleton; Animals; Antineoplastic Agents; Apoproteins; Biphenyl Compounds; Cell Adhesion; Cell Line; Cell Movement; Cell Survival; Coordination Complexes; Gallic Acid; Humans; Mice; Picrates; Pyridines; Ruthenium; Serum Albumin, Bovine; Transferrin; Triple Negative Breast Neoplasms

2021
Noninvasive
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:1

    Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice; Positron-Emission Tomography; Proto-Oncogene Proteins c-myc; Radioisotopes; Transferrin; Triple Negative Breast Neoplasms; Zirconium

2018
Surface-enhanced Raman scattering investigation of targeted delivery and controlled release of gemcitabine.
    International journal of nanomedicine, 2017, Volume: 12

    Topics: Antineoplastic Agents; Cell Line, Tumor; Delayed-Action Preparations; Deoxycytidine; Doxorubicin; Drug Delivery Systems; Female; Folic Acid; Gemcitabine; Gold; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Molecular Targeted Therapy; Spectrum Analysis, Raman; Transferrin; Triple Negative Breast Neoplasms

2017
Remotely Phototriggered, Transferrin-Targeted Polymeric Nanoparticles for the Treatment of Breast Cancer.
    Photochemistry and photobiology, 2018, Volume: 94, Issue:4

    Topics: Apoptosis; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Microscopy, Fluorescence; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Polymers; Transferrin; Triple Negative Breast Neoplasms; Verteporfin

2018
Transport of the Ruthenium Complex [Ru(GA)(dppe)
    Molecular pharmaceutics, 2019, 03-04, Volume: 16, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Biological Transport, Active; Cell Line, Tumor; Cell Movement; Cisplatin; Coordination Complexes; DNA, Neoplasm; Female; Gallic Acid; Humans; Ligands; Molecular Structure; Neoplasm Invasiveness; Receptors, Transferrin; Ruthenium; Serum Albumin, Human; Transferrin; Triple Negative Breast Neoplasms

2019